Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision

Abstract. Wide local excision (WLE) of tumors with negative margins remains a challenge because surgeons cannot directly visualize the mass. Fluorescence-guided surgery (FGS) may improve surgical accuracy; however, conventional methods with direct surface tumor visualization are not immediately applicable, and properties of tissues surrounding the cancer must be considered. We developed a phantom model for sarcoma resection with the near-infrared fluorophore IRDye 800CW and used it to iteratively define the properties of connective tissues that typically surround sarcoma tumors. We then tested the ability of a blinded surgeon to resect fluorescent tumor-simulating inclusions with ∼1-cm margins using predetermined target fluorescence intensities and a Solaris open-air fluorescence imaging system. In connective tissue-simulating phantoms, fluorescence intensity decreased with increasing blood concentration and increased with increasing intralipid concentrations. Fluorescent inclusions could be resolved at ≥1-cm depth in all inclusion concentrations and sizes tested. When inclusion depth was held constant, fluorescence intensity decreased with decreasing volume. Using targeted fluorescence intensities, a blinded surgeon was able to successfully excise inclusions with ∼1-cm margins from fat- and muscle-simulating phantoms with inclusion-to-background contrast ratios as low as 2∶1. Indirect, subsurface FGS is a promising tool for surgical resection of cancers requiring WLE.

[1]  C. Tzeng,et al.  Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma , 2011, Journal of surgical oncology.

[2]  D. Goldstein,et al.  Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma , 2017, International journal of molecular sciences.

[3]  M. Bernstein,et al.  The role of 5‐aminolevulinic acid in enhancing surgery for high‐grade glioma, its current boundaries, and future perspectives: A systematic review , 2016, Cancer.

[4]  M. Bouvet,et al.  Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma , 2015, Oncotarget.

[5]  B. Pogue,et al.  Imaging breast adipose and fibroglandular tissue molecular signatures by using hybrid MRI-guided near-infrared spectral tomography. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Doniel Drazin,et al.  Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors. , 2014, Neurosurgical focus.

[7]  D H Leung,et al.  Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Bouvet,et al.  Eradication of osteosarcoma by fluorescence‐guided surgery with tumor labeling by a killer‐reporter adenovirus , 2016, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  Axel Hoos,et al.  Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas , 2002, Annals of surgery.

[10]  B. Pogue,et al.  Application of Fluorescence-Guided Surgery to Subsurface Cancers Requiring Wide Local Excision , 2018, Cancer control : journal of the Moffitt Cancer Center.

[11]  Scott C Davis,et al.  Topical dual-stain difference imaging for rapid intra-operative tumor identification in fresh specimens. , 2013, Optics letters.

[12]  J. Olson,et al.  Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent , 2017, International journal of toxicology.

[13]  Joshua S Richman,et al.  Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer , 2015, Clinical Cancer Research.

[14]  Brian W. Pogue,et al.  High Vascular Delivery of EGF, but Low Receptor Binding Rate Is Observed in AsPC-1 Tumors as Compared to Normal Pancreas , 2011, Molecular Imaging and Biology.

[15]  H. J. van Staveren,et al.  Light scattering in Intralipid-10% in the wavelength range of 400-1100 nm. , 1991, Applied optics.

[16]  Brian W Pogue,et al.  Advancing molecular-guided surgery through probe development and testing in a moderate cost evaluation pipeline , 2015, Photonics West - Biomedical Optics.

[17]  Johannes E. Schindelin,et al.  The ImageJ ecosystem: An open platform for biomedical image analysis , 2015, Molecular reproduction and development.

[18]  Sanjiv S. Gambhir,et al.  Endoscopic molecular imaging of human bladder cancer using a CD47 antibody , 2014, Science Translational Medicine.

[19]  Jason R. Gunn,et al.  In Vivo Quantification of Tumor Receptor Binding Potential with Dual-Reporter Molecular Imaging , 2012, Molecular Imaging and Biology.

[20]  E. Rosenthal,et al.  Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma , 2013, Molecular Imaging and Biology.

[21]  H. Grossman,et al.  Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. , 2010, The Journal of urology.

[22]  Brian W. Pogue,et al.  Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody , 2013, PloS one.

[23]  Jeffrey K. Mito,et al.  A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer , 2016, Science Translational Medicine.

[24]  Brian W Pogue,et al.  Microdose fluorescence imaging of ABY-029 on an operating microscope adapted by custom illumination and imaging modules. , 2016, Biomedical optics express.

[25]  Brian W. Pogue,et al.  Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions , 2016, Molecular Imaging and Biology.

[26]  Jia-Lin Yang,et al.  Expression of HER1/EGFR protein in human soft tissue sarcomas. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  Tayyaba Hasan,et al.  Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach. , 2014, Cancer research.

[28]  J. Coll,et al.  Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans , 2015, European Archives of Oto-Rhino-Laryngology.

[29]  Xiaoyao Fan,et al.  Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. , 2011, Journal of neurosurgery.

[30]  B. Rice,et al.  Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors. , 2015, Cancer research.

[31]  Brian W Pogue,et al.  Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging , 2016, Journal of biomedical optics.

[32]  Alexander L Vahrmeijer,et al.  Oncologic Procedures Amenable to Fluorescence-guided Surgery , 2017, Annals of surgery.

[33]  E. Rosenthal,et al.  Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation , 2017, Molecular Imaging and Biology.

[34]  Jeffrey K. Mito,et al.  Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging , 2012, Cancer.

[35]  E. Rosenthal,et al.  Fluorescent labeled anti‐EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model , 2008, Head & neck.

[36]  Tayyaba Hasan,et al.  Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imaging , 2014, Nature Medicine.

[37]  Bin Chen,et al.  Fluorescence Imaging in Vivo: Raster Scanned Point-Source Imaging Provides More Accurate Quantification than Broad Beam Geometries , 2004, Technology in cancer research & treatment.

[38]  S. Jacques Optical properties of biological tissues: a review , 2013, Physics in medicine and biology.

[39]  A. Stojadinovic,et al.  Impact of margin status and local recurrence on soft-tissue sarcoma outcomes. , 2013, The Journal of bone and joint surgery. American volume.

[40]  Keith Paulsen,et al.  Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use , 2017, Molecular Imaging and Biology.

[41]  Brian W Pogue,et al.  Nodal lymph flow quantified with afferent vessel input function allows differentiation between normal and cancer-bearing nodes. , 2015, Biomedical optics express.

[42]  O. Merimsky,et al.  Expression and significance of EGFR in malignant peripheral nerve sheath tumor , 2008, Journal of Neuro-Oncology.

[43]  Eva M. Sevick-Muraca,et al.  Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats , 2010, Molecular Imaging and Biology.

[44]  E. Rosenthal,et al.  Use of Panitumumab-IRDye800 to Image Microscopic Head and Neck Cancer in an Orthotopic Surgical Model , 2012, Annals of Surgical Oncology.

[45]  Maximilian Burger,et al.  Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. , 2012, The Journal of urology.

[46]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[47]  H. Park,et al.  The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[48]  Sophie J Deharvengt,et al.  Dynamic dual-tracer MRI-guided fluorescence tomography to quantify receptor density in vivo , 2013, Proceedings of the National Academy of Sciences.

[49]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[50]  T. Yamashita,et al.  Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas , 2005, Cancer.

[51]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.